Northumbria University Newcastle Newcastle

Information

Name

Type

Company

Roles

Buyer

Company Size

Company Number

Incorporation Date

Website

https://northumbria.ac.uk

Address

Newcastle upon Tyne

United Kingdom

Suppliers

ADELPHI DIGITAL CONSULTING GROUP LTD

Information technology consultancy activities
DU Biosciences
IP2Impact
Giles Wilson
Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Northumbria University Newcastle Newcastle
Sign up free

Contracts awarded by Northumbria University Newcastle Newcastle

These are contracts have closed and been awarded by Northumbria University Newcastle Newcastle to a company or companies. Click on the contract to view more detailed information and view the full details about the winning bid/company.

Award

Published 1 year ago

(NU/1433-44) Senseful AI: The Provision of Business Consultancy to Assist Commercialisation of University Research

As a professional philologist whose research rests at the intersection of linguistics, anthropology, and the cognitive sciences, Dr William Short (PhD, University of California, Berkeley) has pioneered the development of an approach to the description of the conceptual systems of historical societies through the close analysis of language and text. As part of this research, Dr Short developed an innovative search engine technology that enables the identification of relations between concepts within large text corpora, independent of how those concepts happen to be expressed lexically. Seeing this tool’s potential to make searching textual data of all kinds more efficient, more productive, and more rewarding, Dr Short has launched Senseful AI to commercialise the technology for data providers hoping to offer advanced, sophisticated search functionalities to their users. We are looking for an Executive with the initial brief of the executive will be to: Phase 1 Opportunity validation and business plan creation Review existing business ambitions and options for optimal route to market and generate a viable business plan with realistic funding requirements built on sound market research Phase 2 Spinout approval Work with University of Exeter’s technology transfer office and founder academics to develop business case to obtain approval and sign-off for the spin-out company creation Phase 3 Complete necessary stages for being “ready to spin” including company formation relevant legal agreements. Phase 4 Securing seed investment into the company Achieve investor engagement, commitment and completing a Term Sheet and investment completion, to cover funding required by the business to deliver against the business plan.

£30,000
Award

Published 1 year ago

(NU/1433-36) IndigoDX Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

1 in 5 adults in the UK suffer from urinary symptoms caused by an overactive bladder (OAB). Symptoms include urgency (a sudden compelling desire to pass urine, which cannot be deferred), increased frequency of voiding (both day and night) and urge incontinence (involuntary leakage accompanied by / immediately preceded by urgency). The Team wishes to establish a spinout company to produce a Dipstick-style test. Our discovery is currently being developed into a simple-to-use diagnostic tool used for (1) regular screening for OAB in adults, at a GP surgery, pharmacy or nursing home, and (2) to assess the effectiveness of treatments (companion diagnostic) and modifying dosing/treatments accordingly. Accurate and early diagnosis will improve treatment outcomes, eliminating the need for patients to have invasive and high-risk surgery-led second-line treatments necessary for advanced-stage disease. Currently there is no competition for a non-invasive biomarker-based test, and new product development activity appears to be very limited, suggesting an opportunity for ‘first mover advantage’ and to establish a standard. We require a driven executive to take this technology forward and build a compelling proposition for investment. The Executive will need to create a robust business model that is acceptable to the founders, develop and deliver pitch materials for investors and establish collaborative research projects. The executive appointed should have an appropriate background, ideally with experience of high tech starts ups, securing seed investment and establishing manufacturing facilities.

£30,000
Award

Published 1 year ago

(NU/1433-39) EcoTech Devices: The Provision of Business Consultancy to Assist Commercialisation of University Research.

The Northumbria University team have developed two complementary ecotechnologies (namely, Solar2water and OptimumAirCon) though they may be targeting different market applications. Solar2water is an innovative atmospheric water generator (AWG) while OptimumAirCon is an innovative indirect evaporative cooling system (IEC). The aim is to create a spin-out company ‘EcoTech Devices Limited’ which will market and sell products globally (esp. in hot climatic regions and/or off-grid requirement scenarios) based on the two ecotechnologies. The initial brief of the executive will be to: (1) Produce a viable 5 year business plan; (2) Obtain university approval for the venture; a. Act for the company in the spin-out legal process and address all company formation matters; b. Provide to the appropriate university all matters necessary for Research England reporting requirements; (3) Finalise market-ready product spec and validate TAM (Total Addressable Market) (4) Engage with angels/VCs to attempt funding and promote to international partners

£30,000
Award

Published 1 year ago

(NU/1433- 41) IngeniumAI: The Provision of Business Consultancy to Assist Commercialisation of University Research.

At IngeniumAI we aim to address the unnecessary delays in disease diagnosis. Currently the diagnosis of many diseases takes far too long. For example, to receive a diagnosis the average pulmonary hypertension (PH) patient has 5.3 GP visits and 3 referrals, taking on average 2 years, 2 months. By this point treatment options are severely limited. If left untreated the average time to mortality is only 2 years, 6 months. Delays in diagnosis of PH are estimated to cost more than £27,000 per patient in additional healthcare resources and more than £100,000 in wider economic costs. The total UK cost is more than £250m per year, most of which could be eliminated with early screening. Globally these delays cause approximately 300,000 unnecessary deaths per year. We are responding to the opportunity by developing software to automatically analyse routine CT scans to enable early screening for diseases.

£30,000

Contacts

[email protected]

Northumbria University Newcastle Newcastle

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded by Northumbria University Newcastle Newcastle

(NU/1433-44) Senseful AI: The Provision of Business Consultancy to Assist Commercialisation of University Research

(NU/1433-36) IndigoDX Ltd: Commercialisation of university research through provision of management skills to assist in successful spin-out company creation

(NU/1433-39) EcoTech Devices: The Provision of Business Consultancy to Assist Commercialisation of University Research.

(NU/1433- 41) IngeniumAI: The Provision of Business Consultancy to Assist Commercialisation of University Research.

Contacts

Statistics (1 Year)